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In the current issue of Revista Brasileira de Psiquiatria,
Clemente et al.1 report the first meta-analysis of the
prevalence of bipolar disorder (BD) from population-
based studies. Strengths of the manuscript include the
use of suitable methods of analysis, reporting both annual
and lifetime prevalence rates, and providing separate
data for bipolar subtypes I and II. The latter is relevant
because type II is not simply a milder or minor form of BD.
This publication is of considerable interest, firstly
because it confirms that the frequency of BD in the
general population is low and closer to the conservative
estimates of 1-2%, as suggested by historical data.2,3 It is
worth pointing out that these might be underestimates
because, compared to longitudinal studies, data from
population-based cross-sectional studies may underesti-
mate the real prevalence of BD.4
More importantly, the authors found an increase in
prevalence estimates over recent decades, in parallel with
changing DSM diagnostic criteria. Lifetime prevalence of
BD type I has virtually doubled with each edition from
DSM-III to DSM-IV. The increase in type II is only
marginally significant, although the number of studies is
also lower. This is quite surprising, since the only relevant
change in the bipolar section of the DSM over the last
three decades was the appearance of BD type II in DSM-
III-R, whereas criteria for type I have remained essentially
the same. In a conservative explanation, the authors
attribute the increase in type I to the use of different
instruments, whereas growth in type II frequency would
be the result of changing DSM criteria.
However, this meta-analysis leaves some key ques-
tions ‘‘blowing in the wind.’’ For instance, how much of
this growth is real or artifactual? In other words, is it the
result of increased awareness by clinicians, more accurate
nosologies, broadening of diagnostic criteria, or just another
vogue? Recently, there has been much controversy about
an epidemic of BD, and psychiatry is facing risks for
both bipolar ‘‘overdiagnosis’’ and ‘‘underdiagnosis.’’ The
results of this paper will surely fuel the debate. Interestingly,
if one assumes that a genuine increase in bipolar frequency
has taken place, it would be relatively independent of
the gradual expansion of the bipolar phenotype, from
the narrowly-defined ‘‘classic’’ manic-depressive illness
(BD type I) to the broadly-defined ‘‘full bipolar spectrum.’’
The latter may present with higher rates, but is more difficult
to capture; therefore, its prevalence has been less
examined in community samples.
Another fascinating issue is why increased prevalence
in non-clinical samples is more obvious in BD type I. One
could expect a similar, or even greater, trend for BD
type II. Some reflections about hypomania, which lies
between the narrow and broad bipolar phenotypes, merit
further discussion. Recognition of mania is straightfor-
ward, with exceptionally high concordance rates among
clinicians. However, an accurate diagnosis of hypomania
is usually difficult in clinical practice – even more so in
community surveys! On the one hand, patients certainly
do not label hypomania as abnormal. On the other hand,
the successive DSM editions have refined the diagnostic
criteria for hypomania, but its definition remains con-
troversial. Hypomania has not gone through Robins and
Guze’s gold-standard criteria to establish the validity and
reliability of major mental disorders.3 Indeed, its dissec-
tion from mania does not rely on quantity or quality of
symptoms, which are identical, with the exception of
psychotic features. Rather, it is based on the somewhat
arbitrary, non-symptom criteria of minimum duration of
7 days, need for hospitalization, and marked functional
impairment in the case of mania.5 Moreover, marked
impairment is not clearly operationalized in DSM.6 All of
this likely leads to underestimation of the true prevalence
of BD type II, especially in the general population. As
mentioned by the authors, its prevalence is greater in
clinical samples. That also seems to be the case among
adolescents, an age group in which lifetime prevalence
rates of hypomania can reach 3-4% in prospective
community samples.7 This question must await further
inquiry, because the present systematic review focused
only on adult samples. Future meta-analyses should also
reveal whether the inclusion of studies using the ICD
diagnostic system would modify the present findings.
Certainly, establishing the prevalence of bipolar and
other psychiatric disorders is a complex endeavor.
Differences in settings (general population, primary care
vs. psychiatric clinics), types of prevalence estimates
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(e.g., point, 12-month, lifetime), assessment instruments,
and changing diagnostic criteria may affect prevalence
rates and comparisons of studies. These factors may
likely account for much of the discrepancy in the literature
regarding BD prevalence. However, defining the bound-
aries of the phenotype is unique to BD and represents a
major source of this variability, as mentioned above.
BD is among the leading causes of disability worldwide.
Robust and reliable prevalence estimates, such as those
from the present meta-analysis, represent a relevant
addition to the epidemiology of this disorder and have
clinical, socioeconomic, and policy-making implications.
For instance, they may help inform planning of health care
and services. People with BD deserve more effective
treatments, and advancing a better definition, ideally
based on a better understanding of BD neurobiology, is a
key step.6 Clearly, there is substantial room for improve-
ment of our current diagnostic systems. In this regard,
recent proposals, such as clinical staging systems8 and
Research Domain Criteria,9 will hopefully move the field
forward and improve clinical outcomes.
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